Company Data
Citius Pharmaceuticals Inc.
Ticker
CTXR
Current Price
$0.773 0.27%
Market Cap
$122.8M
Price Target
Refer to Report
Volume
560.7K
52wk Range
$0.6 - $1.71
Overview
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company’s Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.